Granulocyte colony-stimulating factor for the induction of T-cell tolerance

Transplantation

Volumn 84, Issue 1 SUPPL., 2007, Pages

  Rutella, Sergio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autoimmune disease; Dendritic cell; Granulocyte colony stimulating factor; IL 10; T cell

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLERGIC ENCEPHALOMYELITIS; CONFERENCE PAPER; DENDRITIC CELL; DIABETES MELLITUS; DRUG EFFECT; ENTERITIS; GRAFT VERSUS HOST REACTION; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 34447535588     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269611.66517.bf     Document Type: Conference Paper

References (51)

1. Rutella S, Zavala F, Danese S, et al. Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance. J Immunol 2005; 175: 7085.
2. Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: Implications for transplantation and autoimmune diseases. Blood 2003; 102: 734.
3. Sloand EM, Kim S, Maciejewski JP, et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000; 95: 2269.
4. Hartung T, Docke WD, Gantner F, et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482.
5. Pollmacher T, Korth C, Mullington J, et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 1996; 87: 900.
6. Kitabayashi A, Hirokawa M, Hatano Y, et al. Granulocyte colonystimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 1995; 86: 2220.
7. low/neg accessory cells with dendritic-cell features. Blood 2006; 108: 218.
8. Rutella S, Bonanno G, Pierelli L, et al. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-α. Eur J Immunol 2004; 34: 1291.
9. Rutella S, Rumi C, Pierelli L, et al. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol 2000; 28: 612.
10. Rutella S, Rumi C, Lucia MB, et al. Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness. Exp Hematol 1998; 26: 1024.
11. Rutella S, Pierelli L, Rumi C, et al. T-cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp Hematol 2001; 29: 401.
12. Tanaka J, Mielcarek M, Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998; 91: 347.
13. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: A mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998; 92: 215.
14. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629.
15. Talmadge JE, Reed EC, Kessinger A, et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101.
16. Rodriguez PC, Quiceno DG, Zabaleta J, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839.
17. Rutella S, Pierelli L, Bonanno G, et al. Role for granulocyte colonystimulating factor in the generation of human T regulatory type 1 cells. Blood 2002; 100: 2562.
18. Morris ES, MacDonald KP, Rowe V, et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 2004; 103: 3573.
19. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64: 8451.
20. +) in the blood of normal donors. Blood 1997; 89: 2586.
21. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685.
22. Arpinati M, Green CL, Heimfeld S, et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484.
23. hi blood dendritic cells with altered CD62L and CCR7 expression. Blood 2003; 101: 2314.
24. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422.
25. Pan L, Teshima T, Hill GR, et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graftversus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93: 4071.
26. Reddy V, Hill GR, Pan L, et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 2000; 69: 691.
27. Remberger M, Naseh N, Aschan J, et al. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Bone Marrow Transplant 2003; 32: 217.
28. Ringden O, Labopin M, Gorin NC, et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004; 22: 416.
29. Ho VT, Mirza NQ, Junco DD, et al. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis. Bone Marrow Transplant 2003; 32: 771.
30. Appelbaum FR. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste? J Clin Oncol 2004; 22: 390.
31. Ringden OT, Le Blanc K, Remberger M. Granulocyte and granulocytemacrophage colony-stimulating factors in allografts: Uses, misuses, misconceptions, and future applications. Exp Hematol 2005; 33: 505.
32. Przepiorka D, Anderlini P, Saliba R, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695.
33. Banovic T, MacDonald KP, Morris ES, et al. TGF-β in allogeneic stem cell transplantation: Friend or foe? Blood 2005; 106: 2206.
34. Volpi I, Perruccio K, Tosti A, et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 2001; 97: 2514.
35. Zavala F, Masson A, Hadaya K, et al. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J Immunol 1999; 163: 5125.
36. Mathian A, Weinberg A, Gallegos M, et al. IFN-α induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J Immunol 2005; 174: 2499.
37. Brendolan A, Higuchi M, Sibley R, Strober S. Treatment of adjuvant arthritis with granulocyte-colony stimulating factor and peptide derived from heat shock protein 65. Cell Immunol 2003; 221: 6.
38. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol 2000; 68: 144.
39. Euler HH, Harten P, Zeuner RA, Schwab UM. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. J Rheumatol 1997; 24: 2153.
40. Snowden JA, Biggs JC, Milliken ST, et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22: 1035.
41. Zavala F, Abad S, Ezine S, et al. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J Immunol 2002; 168: 2011.
42. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500.
43. + regulatory T-cells. Diabetes 2005; 54: 78.
44. Hommes DW, Meenan J, Dijkhuizen S, et al. Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin Exp Immunol 1996; 106: 529.
45. Egi H, Hayamizu K, Yoshimitsu M, et al. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 2003; 23: 23.
46. Dejaco C, Lichtenberger C, Miehsler W, et al. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003; 68: 63.
47. Korzenik JR, Dieckgraefe BK. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther 2005; 21: 391.
48. high regulatory T cells. Blood 2004; 104: 895.
49. Dagia NM, Gadhoum SZ, Knoblauch CA, et al. G-CSF induces Eselectin ligand expression on human myeloid cells. Nat Med 2006; 12: 1185.
50. Vasiliu IM, Petri MA, Baer AN. Therapy with granulocyte colonystimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol 2006; 33: 1878.
51. Openshaw H, Stuve O, Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54: 2147.